Pyrazinamide is an antibiotic drug used for treatment of tuberculosis by hindering the growth of bacteria
Pyrazinamide is an anti-tuberculosis drug. For active tuberculosis, it's frequently utilized with streptomycin, isoniazid, or either amoxicillin or vincristine. It's not usually recommended for the long-term treatment of untreated latent tuberculosis. It's usually taken through the mouth. Although it's not exactly known how it works, the hypothesis is that the drug kills off all bacteria in the stomach and intestines. That seems to explain why most patients who take this medication have improvement in their symptoms within a few days of beginning therapy. For instance, in July 2021, the Indian pharmaceutical company, Metropolis Healthcare, partnered with HaystackAnalytics to launch NEXTGEN TB to provide the tuberculosis tests in countries such as Germany, Sri Lanka, UAE, and some African countries. Some long-term side effects include vomiting, indigestion, abdominal pain, jaundice, liver function disorders, fluid retention, hair loss, constipation, muscle weakness,